• No results found

University of Groningen Circulating microRNAs in heart failure Vegter, Eline Lizet

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Circulating microRNAs in heart failure Vegter, Eline Lizet"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Circulating microRNAs in heart failure

Vegter, Eline Lizet

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2017

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Vegter, E. L. (2017). Circulating microRNAs in heart failure. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Circulating microRNAs in heart failure

(3)

Circulating microRNAs in heart failure ISBN: 978-94-9268-392-2

© Copyright 2017 - E.L. Vegter

All rights are reserved. No part of this publication may be reproduced, stored in a re-trieval system, or transmitted in any form or by any means, without the written permis-sion of the author.

The financial support of the Graduate School of Medical Sciences and the University of Groningen for the publication of this thesis is gratefully acknowledged.

Cover design: Sara ten Broeke en Rik Vegter

(4)

Circulating microRNAs

in heart failure

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 18 oktober 2017 om 14.30 uur

door

Eline Lizet Vegter

geboren op 27 december 1988 te Venlo

(5)

Promotor

Prof. dr. A.A. Voors

Copromotor

Dr. P. van der Meer

Beoordelingscommissie

Prof. dr. J. van der Velden Prof. dr. L.J. de Windt Prof. dr. M.P. van den Berg

Financial support by the Dutch Heart Foundation for the publication of this thesis is gratefully acknowledged. The research described in this thesis was supported by a grant from the Dutch Heart Foundation (CVON 2011-11).

(6)

Paranimfen

Dr. J.C. Tanis Drs. L.V. de Vries

(7)
(8)

TABLE of CoNTENTs

Chapter 1 Introduction and aims 9 Chapter 2 MicroRNAs in heart failure: from biomarker to target for therapy

Eur J Heart Fail. 2016 May;18(5):457-68

23

Chapter 3 Signature of circulating microRNAs in patients with acute heart failure

Eur J Heart Fail. 2016 Apr;18(4):414-23

53

Chapter 4 Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure

Int J Cardiol. 2016 Dec 1;224:231-239

77

Chapter 5 Associations between volume status and circulating microRNAs in acute heart failure

Eur J Heart Fail. 2017 Aug;19(8):1077-1078.

115

Chapter 6 Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations

Clin Res Cardiol. 2017 Aug;106(8):598-609.

123

Chapter 7 Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure

Plos One. 2017 May 5;12(5):e0177242

153

Chapter 8 General discussion and future perspectives 185 Appendices Nederlandse samenvatting 209

Dankwoord 221

About the author 227

(9)

Referenties

GERELATEERDE DOCUMENTEN

Although there is increasing interest in circulating miRNAs in heart failure, there are still major uncertainties about their origin and function in the circulation. Some speculate

(AHF) patients at admission (Wroclaw, validation study) compared with healthy controls (continued) miRNAs fold change P-value miRNAs fold change P-value. (AHf vs. controls)

The majority of correlations between circulating AHF-specific miRNAs were related to biomarkers predictive for a worse clinical outcome in a subgroup of worsening heart failure

Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study

Although the precise functions of circulating miRNAs in heart failure are still elusive, this study proposes a link between downregulated heart failure-related miRNAs and the

culating blood the function of miRNAs is largely unknown. The discovery of circulating miRNAs attracted strong attention in several diseases, including heart failure, as it was

Moreover, several associations between miRNAs and other, well-known and novel heart failure-related biomarkers were identified in patients with worsening heart failure, and

Biomarkers kunnen (patho)fysiologische processen reflecteren en infor- matie geven over de gezondheidstoestand van patiënten, zo ook bij hartfalen.. kunnen ze behulpzaam zijn in